Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease

Neurochemical Research

Volumn 32, Issue 1, 2007, Pages 99-105

  Sánchez Iglesias, Sofía ^a   Rey, Pablo ^a   Méndez Álvarez, Estefanía ^a   Labandeira García, José Luis ^a   Soto Otero, Ramón ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

6 Hydroxydopamine; Lipid peroxidation; Oxidative damage; Parkinson's disease; Protein oxidation

Indexed keywords

OXIDOPAMINE; OXYGEN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; LIPID PEROXIDATION; MALE; MESENCEPHALON; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RAT;

ANIMALS; CORPUS STRIATUM; KETONES; LIPID PEROXIDATION; MALE; MESENCEPHALON; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33845885131     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9232-6     Document Type: Article

References (40)

1. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909
2. Aebischer P, Tresco PA, Sagen J et al (1991) Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 560:43-49
3. He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187-193
4. López-Real A, Rey P, Soto-Otero R et al (2005) Antiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of parkinsonism. J Neurosci Res 81:865-873
5. Muñoz AM, Rey P, Soto-Otero R et al (2004) Systemic administration of N-acetylcysteine protects dopaminergic neurons against 6-hydroxydopamine- induced degeneration. J Neurosci Res 76:551-562
6. Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras A et al (2002) Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease. Biochem Pharmacol 64:125-135
7. Luthman J, Fredriksson A, Sundstorm E et al (1989) Selective lesion of central dopamine or noradrenaline neuron systems in the neonatal rat: motor behaviour and monoamine alterations at adult stage. Behav Brain Res 33:267-277
8. Garver DL, Cedarbaum J, Maas JW (1975) Blood-brain barrier to 6-hydroxydopamine: uptake by heart and brain. Life Sci 17:1081-1084
9. Javoy F, Sotelo C, Herbert A et al (1976) Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostratal dopamine system. Brain Res 102:210-215
10. Ungerstdt U (1971) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol Scand 367(Suppl):1-48
11. Ichitani I, Okamura H, Matsumoto Y et al (1991) Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res 549:330-353
12. Marti MJ, James CJ, Oo TF et al (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 17:2030-2039
13. Méndez-Álvarez E, Soto-Otero R, Hermida-Ameijeiras A et al (2001) Effect of iron and manganese on hydroxyl radical production by 6-hydroxydopamine: mediation of antioxidants. Free Radical Biol Med 31:986-998
14. Soto-Otero R, Méndez-Álvarez E, Hermida-Ameijeiras A et al (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74:1605-1612
15. Glinka YY, Youdim MBH (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol 292:329-332
16. Glinka Y, Tipton KF, Youdim MBH (1996) Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J Neurochem 66(1996) 2004-2010
17. Glinka Y, Tipton KF, Youdim MBH (1998) Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine. Eur J Pharmacol 351:121-129
18. Brand MD, Affourtit C, Esteves TC et al (2004) Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radical Biol Med 37:755-767
19. Yamamuro A, Yoshioka Y, Ogita K et al (2006) Involvement of endoplasmic reticulum stress on the cell death induced by 6-hydroxydopamine in human neuroblastoma SH-SY5Y cells. Neurochem Res 31:657-664
20. Jeon BS, Jackson-Lewis V, Burke RE (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4:131-137
21. Jonsson G (1983) Chemical lesioning techniques: monoamine neurotoxins. In: Björklund A, Hökfelt T (eds) Handbook of Chemical Neuroanatomy. Methods in Chemical Neuroanatomy. Elsevier Science Publisher BV, Amsterdam, 463-507
22. Jiang H, Jackson-Lewis V, Muthane U et al (1993) Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behaviour in 6-hydroxydopamine-lesioned rats. Brain Res 613:347-351
23. Björklund LM, Sanchez-Pemaute R, Chung S et al (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99:2344-2349
24. Markwell MAK, Haas SM, Bieber LL et al (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210
25. Hermida-Ameijeiras A, Méndez-Álvarez E, Sánchez-Iglesias S et al (2004) Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions. Neurochem Int 45:103-116
26. Méndez-Álvarez E, Soto-Otero R, Hermida-Ameijeiras A et al (2002) Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. Biochim Biophys Acta 1586:155-168
27. Przedborski S, Levivier M, Jiang H et al (1995) Dose-dependent lesions of the dopaminergic nigrostriatal pathway induce by intrastriatal injection of 6-hydroxydopamine. Neuroscience 67:631-647
28. Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59:401-415
29. Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence. Nat Med 10:S18-S25
30. Przedborski S, Tieu K, Perier et al (2004) MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J Bioenerg Biomembr 36:375-379
31. Giasson BI, Lee VM (2000) A new link between pesticides and Parkinson's disease. Nat Neurosci 3:1227-1228
32. Giasson BI, Duda JE, Murray IV et al (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration is synucleinopathy lesions. Science 290:985-989
33. Trojanowski JQ, Lee M-Y (2003) Parkinson's disease and related α-synucleinopathies are brain amyloidoses. Ann NY Acad Sci 991:107-110
34. Krantic S, Mechawar N, Reix S et al (2005) Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci 28:670-676
35. Cutillas B, Espejo M, Gil J et al (1999) Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration. NeuroReport 10:2605-2608
36. Przedborski S, Goldman JE (2004) Pathogenic role of glia cells in Parkinson's disease. In: Hertz L (ed) Non-neuronal cells of the nervous system: function and dysfunction. Elsevier, New York, 967-982
37. Rodrigues RW, Gomide VC, Chadi G (2001) Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci 109:91-126
38. Kamsler A, Segal M (2004) Hydrogen peroxide as a diffusible signal molecule in synaptic plasticity. Mol Neurobiol 29:167-178
39. Vroegop SM, Decker DE, Buxser SE (1995) Localization of damage induced by reactive oxygen species in cultured cells. Free Radic Biol Med 18:141-151
40. Lee CS, Sauer H, Björklund A (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641-653